Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 22;20(1):34.
doi: 10.1186/s12893-020-00696-w.

Minimally invasive comprehensive treatment for granulomatous lobular mastitis

Affiliations

Minimally invasive comprehensive treatment for granulomatous lobular mastitis

Yaohuai Wang et al. BMC Surg. .

Abstract

Objective: To describe a minimally invasive comprehensive treatment for granulomatous lobular mastitis (GLM) and compare its effect with the existing methods, particularly in terms of its recurrence rate and esthetic outcomes.

Methods: This retrospective study reviewed 69 GLM patients receiving the minimally invasive comprehensive treatment. Patients' information, including age, clinical features, image characteristics, histopathological findings, mastitis history, treatment process, operative technique, recurrence, and esthetic effect, was evaluated.

Results: All patients were female with a median age of 32 (range 17-55) years. Hospital stays ranged from 2 to 34 days, with a median of 6 days. The shortest time for complete rehabilitation was 2 days and the longest time was 365 days, with a median of 30 days. After a median follow-up of 391 days (range 162-690), 7 patients (10.14%) relapsed. The average cosmetic score was 2.62 ± 0.57 points and was mainly related to the past treatment, especially the surgical history.

Conclusion: Minimally invasive comprehensive treatment is a new method for the treatment of GLM, ensuring a therapeutic effect while maintaining breast beauty.

Keywords: Esthetic outcomes; Granulomatous lobular mastitis; Minimally invasive comprehensive treatment; Non-lactating mastitis; Recurrence rate.

PubMed Disclaimer

Conflict of interest statement

The authors declare that #they have no competing interests.

Figures

Fig. 1
Fig. 1
The workflow of minimally invasive comprehensive treatment
Fig. 2
Fig. 2
Irrigation of lesions. Normal saline was injected into the lesion through the indwelling hoses. Please note that liquid is flowing out of the other indwelling hoses and surgical inlets, indicating that the indwelling hoses are unobstructed

References

    1. Kessler E, Wolloch Y. Granulomatous mastitis: a lesion clinically simulating carcinoma. Am J Clin Pathol. 1972;58(6):642–646. doi: 10.1093/ajcp/58.6.642. - DOI - PubMed
    1. Al Manasra AR, Al-Hurani MF. Granulomatous mastitis: a rare cause of male breast lump. Case Rep Oncol. 2016;9(2):516–519. doi: 10.1159/000448990. - DOI - PMC - PubMed
    1. Velidedeoglu M, Kilic F, Mete B, Yemisen M, Celik V, Gazioglu E, et al. Bilateral idiopathic granulomatous mastitis. Asian J Surg. 2016;39(1):12–20. doi: 10.1016/j.asjsur.2015.02.003. - DOI - PubMed
    1. Oddo D, Dominguez F, Gomez N, Mendez GP, Navarro ME. Granulomatous lobular mastitis associated with ductal carcinoma in situ of the breast. SAGE Open Med Case Rep. 2019;7:2050313x19836583. - PMC - PubMed
    1. Zhou F, Yu L-X, Ma Z-B, Yu Z-G. Granulomatous lobular mastitis. Chronic Dis Transl Med. 2016;2(1):17–21. doi: 10.1016/j.cdtm.2016.02.004. - DOI - PMC - PubMed